Lymphotoxin-α1β2 and LIGHT induce classical and noncanonical NF-κB-dependent proinflammatory gene expression in vascular endothelial cells

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 3467-3477

  Madge, Lisa A ^a   Kluger, Martin S ^b   Orange, Jordan S ^c   May, Michael J ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; LIGHT LIGAND; LYMPHOTOXIN ALPHA BETA; LYMPHOTOXIN BETA RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; HERPESVIRUS ENTRY MEDIATOR LIGAND; LTB PROTEIN, HUMAN; LYMPHOTOXIN; LYMPHOTOXIN BETA; TNFSF14 PROTEIN, HUMAN;

ARTICLE; CANONICAL ANALYSIS; CELL ADHESION; CHRONIC DISEASE; CONTROLLED STUDY; ECTOPIC ORGAN; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOID ORGAN; MICROENVIRONMENT; MICROVASCULATURE; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; BIOSYNTHESIS; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN; T LYMPHOCYTE SUBPOPULATION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; LIGANDS; LYMPHOTOXIN ALPHA1, BETA2 HETEROTRIMER; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; NF-KAPPA B; SIGNAL TRANSDUCTION; SKIN; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; UP-REGULATION;

EID: 48149114957     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.3467     Document Type: Article

References (57)

1. Choi, J., D. R. Enis, K. P. Koh, S. L. Shiao, and J. S. Pober. 2004. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22: 683-709.
2. De Martin, R., M. Hoeth, R. Hofer-Warbinek, and J. A. Schmid. 2000. The transcription factor NF-κB and the regulation of vascular cell function. Arterioscler. Thromb. Vasc. Biol. 20: E83-E88.
3. Collins, T., M. A. Read, A. S. Neish, M. Z. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9: 899-909.
4. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κB. Genes Dev. 18: 2195-2224.
5. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554.
6. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278: 860-866.
7. Rothwarf, D. M., E. Zandi, G. Natoli, and M. Karin. 1998. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 395: 297-300.
8. Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252.
9. Bonizzi, G., M. Bebien, D. C. Otero, K. E. Johnson-Vroom, Y. Cao, D. Vu, A. G. Jegga, B. J. Aronow, G. Ghosh, R. C. Rickert, and M. Karin. 2004. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23: 4202-4210.
10. Dejardin, E., N. M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z. W. Li, M. Karin, C. F. Ware, and D. R. Green. 2002. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17: 525-535.
11. Senftleben, U., Y. Cao, G. Xiao, F. R. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, and M. Karin. 2001. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293: 1495-1499.
12. Bonizzi, G., and M. Karin. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280-288.
13. Denk, A., M. Goebeler, S. Schmid, I. Berberich, O. Ritz, D. Lindemann, S. Ludwig, and T. Wirth. 2001. Activation of NF-κB via the IκB kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J. Biol. Chem. 276: 28451-28458.
14. Kempe, S., H. Kestler, A. Lasar, and T. Wirth. 2005. NF-κB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res. 33: 5308-5319.
15. Claudio, E., K. Brown, S. Park, H. Wang, and U. Siebenlist. 2002. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat. Immunol. 3: 958-965.
16. Coope, H. J., P. G. Atkinson, B. Huhse, M. Belich, J. Janzen, M. J. Holman, G. G. Klaus, L. H. Johnston, and S. C. Ley. 2002. CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J. 21: 5375-5385.
17. Derudder, E., E. Dejardin, L. L. Pritchard, D. R. Green, M. Korner, and V. Baud. 2003. RelB/p50 dimers are differentially regulated by tumor necrosis factor-α and lymphotoxin-β receptor activation: critical roles for p100. J. Biol. Chem. 278: 23278-23284.
18. Mordmüller, B., D. Krappmann, M. Esen, E. Wegener, and C. Scheidereit. 2003. Lymphotoxin and lipopolysaccharide induce NF-κB-p52 generation by a co-translational mechanism. EMBO Rep. 4: 82-87.
19. Muller, J. R., and U. Siebenlist. 2003. Lymphotoxin β receptor induces sequential activation of distinct NF-κB factors via separate signaling pathways. J. Biol. Chem. 278: 12006-12012.
20. Yilmaz, Z. B., D. S. Weih, V. Sivakumar, and F. Weih. 2003. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22: 121-130.
21. Xiao, G., M. E. Cvijic, A. Fong, E. W. Harhaj, M. T. Uhlik, M. Waterfield, and S. C. Sun. 2001. Retroviral oncoprotein Tax induces processing of NF-κB2/p100 in T cells: evidence for the involvement of IKKα. EMBO J. 20: 6805-6815.
22. Xiao, G., A. Fong, and S. C. Sun. 2004. Induction of p100 processing by NF-B-inducing kinase involves docking IκB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation. J. Biol. Chem. 279: 30099-30105.
23. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707.
24. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 6: 491-500.
25. Paxian, S., H. Merkle, M. Riemann, M. Wilda, G. Adler, H. Hameister, S. Liptay, K. Pfeffer, and R. M. Schmid. 2002. Abnormal organogenesis of Peyer's patches in mice deficient for NF-κB1, NF-κB2, and Bcl-3. Gastroenterology 122: 1853-1868.
26. Shinkura, R., K. Kitada, F. Matsuda, K. Tashiro, K. Ikuta, M. Suzuki, K. Kogishi, T. Serikawa, and T. Honjo. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase. Nat. Genet. 22: 74-77.
27. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80: 331-340.
28. Yin, L., L. Wu, H. Wesche, C. D. Arthur, J. M. White, D. V. Goeddel, and R. D. Schreiber. 2001. Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice. Science 291: 2162-2165.
29. Browning, J. L., N. Allaire, A. Ngam-Ek, E. Notidis, J. Hunt, S. Perrin, and R. A. Fava. 2005. Lymphotoxin-β receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 23: 539-550.
30. Drayton, D. L., X. Ying, J. Lee, W. Lesslauer, and N. H. Ruddle. 2003. Ectopic LT αβ directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197: 1153-1163.
31. Drayton, D. L., S. Liao, R. H. Mounzer, and N. H. Ruddle. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7: 344-353.
32. Mackay, F., G. R. Majeau, P. S. Hochman, and J. L. Browning. 1996. Lymphotoxin β receptor triggering induces activation of the nuclear factor κB transcription factor in some cell types. J. Biol. Chem. 271: 24934-24938.
33. Hochman, P. S., G. R. Majeau, F. Mackay, and J. L. Browning. 1995. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. J. Inflamm. 46: 220-234.
34. Pablos, J. L., B. Santiago, D. Tsay, M. S. Singer, G. Palao, M. Galindo, and S. D. Rosen. 2005. A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-α/β and TNF-α in cultured endothelial cells. BMC Immunol. 6: 6.
35. Chen, M. C., M. J. Hwang, Y. C. Chou, W. H. Chen, G. Cheng, H. Nakano, T. Y. Luh, S. C. Mai, and S. L. Hsieh. 2003. The role of apoptosis signal-regulating kinase 1 in lymphotoxin-β receptor-mediated cell death. J. Biol. Chem. 278: 16073-16081.
36. Delhase, M., M. Hayakawa, Y. Chen, and M. Karin. 1999. Positive and negative regulation of IkappaB kinase activity through IKKβ subunit phosphorylation. Science 284: 309-313.
37. Okada, T., V. N. Ngo, E. H. Ekland, R. Forster, M. Lipp, D. R. Littman, and J. G. Cyster. 2002. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196: 65-75.
38. Phillips, R., and A. Ager. 2002. Activation of pertussis toxin-sensitive CXCL12 (SDF-1) receptors mediates transendothelial migration of T lymphocytes across lymph node high endothelial cells. Eur. J. Immunol. 32: 837-847.
39. Scimone, M. L., T. W. Felbinger, I. B. Mazo, J. V. Stein, U. H. Von Andrian, and W. Weninger. 2004. CXCL12 mediates CCR7-independent homing of central memory cells, but not naive T cells, in peripheral lymph nodes. J. Exp. Med. 199: 1113-1120.
40. Hauer, J., S. Puschner, P. Ramakrishnan, U. Simon, M. Bongers, C. Federle, and H. Engelmann. 2005. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. USA 102: 2874-2879.
41. Liao, G., M. Zhang, E. W. Harhaj, and S. C. Sun. 2004. Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279: 26243-26250.
42. Grech, A. P., M. Amesbury, T. Chan, S. Gardam, A. Basten, and R. Brink. 2004. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells. Immunity 21: 629-642.
43. Kim, Y. S., S. A. Nedospasov, and Z. G. Liu. 2005. TRAF2 plays a key, non-redundant role in LIGHT-lymphotoxin β receptor signaling. Mol. Cell Biol. 25: 2130-2137.
44. Feng, X., M. L. Gaeta, L. A. Madge, J. H. Yang, J. R. Bradley, and J. S. Pober. 2001. Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J. Biol. Chem. 276: 8341-8349.
45. Madge, L. A., M. R. Sierra-Honigmann, and J. S. Pober. 1999. Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1): a nonpharmacological explanation for inhibition of TNF-mediated activation. J. Biol. Chem. 274: 13643-13649.
46. Urbich, C., Z. Mallat, A. Tedgui, M. Clauss, A. M. Zeiher, and S. Dimmeler. 2001. Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation. J. Clin. Invest. 108: 1451-1458.
47. Calderon, T. M., E. A. Eugenin, L. Lopez, S. S. Kumar, J. Hesselgesser, C. S. Raine, and J. W. Berman. 2006. A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 177: 27-39.
48. Baekkevold, E. S., T. Yamanaka, R. T. Palframan, H. S. Carlsen, F. P. Reinholt, U. H. von Andrian, P. Brandtzaeg, and G. Haraldsen. 2001. The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 193: 1105-1112.
49. Ebisuno, Y., T. Tanaka, N. Kanemitsu, H. Kanda, K. Yamaguchi, T. Kaisho, S. Akira, and M. Miyasaka. 2003. Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J. Immunol. 171: 1642-1646.
50. Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95: 258-263.
51. Miyasaka, M., and T. Tanaka. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4: 360-370.
52. Santiago, B., F. Baleux, G. Palao, I. Gutierrez-Canas, J. C. Ramirez, F. Arenzana-Seisdedos, and J. L. Pablos. 2006. CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans. Arthritis Res. Ther. 8: R43.
53. -/- mice causes impaired lymph node development and lymphocyte recruitment. J. Immunol. 173: 2271-2279.
54. Drayton, D. L., G. Bonizzi, X. Ying, S. Liao, M. Karin, and N. H. Ruddle. 2004. IκB kinase complex α kinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue. J. Immunol. 173: 6161-6168.
55. Cipriani, P., A. Franca Milia, V. Liakouli, A. Pacini, M. Manetti, A. Marrelli, A. Toscano, E. Pingiotti, A. Fulminis, S. Guiducci, et al. 2006. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications. Arthritis Rheum. 54: 3022-3033.
56. Pablos, J. L., A. Amara, A. Bouloc, B. Santiago, A. Caruz, M. Galindo, T. Delaunay, J. L. Virelizier, and F. Arenzana-Seisdedos. 1999. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am. J. Pathol. 155: 1577-1586.
57. Salmaggi, A., M. Gelati, B. Pollo, S. Frigerio, M. Eoli, A. Silvani, G. Broggi, E. Ciusani, D. Croci, A. Boiardi, and M. De Rossi. 2004. CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J. Neurooncol. 67: 305-317.